Demographics (2)
- AGE - Age at diagnosis (phv00167619.v12.p8)
- GENDER - Gender (phv00167620.v12.p8)
Disease Events (16)
- diag - Diagnostic Category (Revised INPC). If INPC diagnostic category is missing, then this is Shimada diagnostic category. (phv00167629.v12.p8)
- efscens - Events are described as the first occurrence of relapse, progressive disease, secondary malignancy, or death. (phv00167633.v12.p8)
- efstime - Number of days from diagnosis until the event, or until last contact if no event (phv00167635.v12.p8)
- grade - Grade of Neuroblastic Differentiation (Revised INPC). If INPC grade is missing, then this is Shimada grade. (phv00167627.v12.p8)
- hist - Revised INPC prognostic group (Cancer 2003). If INPC is missing, this is the Shimada classification (JNCI 1984). (phv00167626.v12.p8)
- icdo - ICD-O Topography Code (International Classification of Disease Code) (phv00167630.v12.p8)
- icdo_snomed_description - Either the ICDO code, or the SNOMED code (if ICDO=999 or Unknown) or a Hard-coded value if both codes unknown but information available (phv00167632.v12.p8)
- inss_stage - INSS stage (phv00167623.v12.p8)
- mki - MKI (Revised INPC). If INPC MKI is missing, then this is Shimada MKI. When multiple nodules present in a single Ganglioneuroblastoma, nodular tumor, the higher MKI value is reported. (phv00167628.v12.p8)
- mycn - MYCN status (phv00167624.v12.p8)
- percent_necrosis - Proportion of tumor (necrotic vs viable), as estimated on specimen quality control review by the Biopathology Center in Columbus (phv00167640.v12.p8)
- percent_tumor - Proportion of specimen (tumor vs non-tumor), as estimated on specimen quality control review by the Biopathology Center in Columbus (phv00167639.v12.p8)
- ploidy - Ploidy (phv00167625.v12.p8)
- scens - Events are described as the first occurrence of relapse, progressive disease, secondary malignancy, or death. (phv00167634.v12.p8)
- snomed - Older Topography Code (Systemized Nomenclature of Medicine-Clinical Terms) (phv00167631.v12.p8)
- stime - Number of days from diagnosis until death, or until last contact if alive (phv00167636.v12.p8)
Race and Ethnicity (2)
- NAACCR_ETHNICITY - NAACCR Ethnicity (phv00167621.v12.p8)
- NAACCR_RACE - NAACCR Race (phv00167622.v12.p8)
Other (9)
- ANALYTETYPE - Analyte type (phv00167645.v13.p8)
- COG Risk Group - COG risk stratification criteria at the time the patient enrolled (phv00167637.v12.p8)
- DISEASEPROJECT - Disease project (phv00196459.v9.p8)
- DISEASESTATE - Disease state of sample (phv00167642.v13.p8)
- EXTRACTNAME - Extract name (phv00167643.v13.p8)
- Protocol(s) - COG Protocol number on which the patient was enrolled (phv00167638.v12.p8)
- SAMPLENAME - Sample Name (phv00167641.v13.p8)
- SAMPLETYPE - Sample type (phv00167644.v13.p8)
- SUBJID - TARGET Subject id (phv00167618.v12.p8)